Cancer immune suppression in pancreatic cancer appears to be mediated by CXCL 12, the chemokine that binds to cancer cells and excludes T cells by a mechanism that is dependent on the CXCL 12 receptor CXCR4 [31,62] (Table 1). The gene discussed is CXCR4; the disease is familial pancreatic carcinoma.